CNC — Centene Corp.

Centene Corporation Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Diluted Earnings Per Share (EPS): $2.51, exceeding expectations.
• Full-Year 2026 Adjusted EPS Guidance: Increased to greater than $4.80 from prior guidance of greater than $3.40.
• Total Revenue: $44.4 billion in premium and service revenue.
• Consolidated Health Benefits Ratio (HBR): 89.6%, down from 93% in Q2 2025.
• Medicaid Membership: 12.1 million members, with an expected decline of 8-9% by year-end.
• Medicare Segment HBR: 89.5%, with an expected pretax margin for PDP of greater than 3%.
• Marketplace Segment HBR: 79.2%, with a revised pretax margin guidance of 4.5% to 5%.

2. Strategic Updates and Business Highlights

• Medicaid: Focused on operational execution and quality improvements, achieving better-than-expected rate adjustments and maintaining disciplined cost management.
• Medicare: Continued strength in both Medicare Advantage and PDP segments, with plans to simplify the Medicare Advantage footprint and enhance offerings for dual-eligible members.
• Marketplace: Successful recovery of margins through improved risk adjustment and cost management, with a strong focus on member engagement and community outreach.
• AI and Technology Investments: Emphasis on building foundational capabilities to enhance data management and operational efficiency, with a focus on ROI from AI initiatives.

3. Forward Guidance and Outlook

• Membership Trends: Anticipated decline in Medicaid membership due to state-specific program changes and increased enrollment activity.
• Rate Adjustments: Expecting full-year Medicaid rate impact to improve from 4.5% to 5%.
• 2027 Outlook: While specific guidance is not provided, there is confidence in margin recovery despite anticipated headwinds from regulatory changes (OB3).

4. Bad News, Challenges, or Points of Concern

• Membership Attrition: Higher-than-expected attrition in Medicaid, particularly in the expansion population, which could impact future acuity and margins.
• Regulatory Changes: Uncertainty surrounding the implementation of OB3 and its potential impact on Medicaid funding and member eligibility.
• Cost Pressures: Elevated medical costs in certain segments, particularly Medicare, although these are being managed effectively.
• Market Dynamics: Competitive pressures in the ACA marketplace and potential impacts from ongoing litigation affecting membership growth.

5. Notable Q&A Insights

• Medicaid Acuity: Slight uptick in acuity due to membership attrition, with management confident in their ability to absorb these changes through operational strength.
• Pricing Strategy for 2027: Emphasis on a state-by-state approach to pricing, focusing on margin restoration while remaining competitive.
• Impact of Low Utilizers: Notable decrease in low utilizers in Medicaid, particularly in the expansion population, which is being closely monitored.
• AI Investments: Strategic focus on foundational data capabilities rather than broad deployment of AI, ensuring a high ROI on technology investments.
• Funding Environment: Management believes that budget pressures on states may lead to productive conversations about maintaining Medicaid benefits without further cuts.

Overall, Centene reported strong Q2 results with improved guidance for the year, while navigating challenges related to membership attrition and regulatory changes. The company remains focused on operational efficiency and quality improvements across its segments.